General Information of Drug Combination (ID: DCDHZFS)

Drug Combination Name
Ceftriaxone Octreotide
Indication
Disease Entry Status REF
Variceal Hemorrhage Phase 1 [1]
Component Drugs Ceftriaxone   DMCEW64 Octreotide   DMHIDCJ
Small molecular drug Small molecular drug
2D MOL 2D MOL
3D MOL 3D MOL is unavailable

Molecular Interaction Atlas of This Drug Combination

Molecular Interaction Atlas (MIA)
Indication(s) of Ceftriaxone
Disease Entry ICD 11 Status REF
Acute gonococcal cervicitis N.A. Approved [2]
Bacteremia 1A73 Approved [2]
Bacterial arthritis N.A. Approved [2]
Bacterial infection 1A00-1C4Z Approved [3]
Chancroid N.A. Approved [2]
Endometritis N.A. Approved [2]
Escherichia coli meningitis N.A. Approved [2]
Gonococcal infection of joint N.A. Approved [2]
Meningococcal meningitis N.A. Approved [2]
Pneumococcal meningitis N.A. Approved [2]
Staphylococcal pneumonia N.A. Approved [2]
Pelvic inflammatory disease GA05 Investigative [2]
Ceftriaxone Interacts with 1 DTT Molecule(s)
DTT Name DTT ID UniProt ID Mode of Action REF
Bacterial Penicillin binding protein (Bact PBP) TTJP4SM NOUNIPROTAC Modulator [6]
------------------------------------------------------------------------------------
Ceftriaxone Interacts with 4 DTP Molecule(s)
DTP Name DTP ID UniProt ID Mode of Action REF
Multidrug resistance-associated protein 2 (ABCC2) DTFI42L MRP2_HUMAN Substrate [7]
P-glycoprotein 1 (ABCB1) DTUGYRD MDR1_HUMAN Substrate [7]
Peptide transporter 1 (SLC15A1) DT9G7XN S15A1_HUMAN Substrate [8]
Organic anion transporting polypeptide 1B3 (SLCO1B3) DT9C1TS SO1B3_HUMAN Substrate [9]
------------------------------------------------------------------------------------
Ceftriaxone Interacts with 3 DME Molecule(s)
DME Name DME ID UniProt ID Mode of Action REF
Beta-lactamase (blaB) DEEAL81 BLA2_KLEPO Metabolism [10]
Beta-lactamase (blaB) DEYIEO5 AMPC_SERMA Metabolism [11]
Beta-lactamase (blaB) DEBKS91 A0A1B1FBM9_ACIBA Metabolism [12]
------------------------------------------------------------------------------------
Ceftriaxone Interacts with 1 DOT Molecule(s)
DOT Name DOT ID UniProt ID Mode of Action REF
Dihydrofolate reductase (DHFR) OT3DVIGM DYR_HUMAN Decreases Activity [13]
------------------------------------------------------------------------------------
Indication(s) of Octreotide
Disease Entry ICD 11 Status REF
Acromegaly 5A60.0 Approved [4]
Carcinoid syndrome 5B10 Approved [5]
Diabetic retinopathy 9B71.0 Approved [5]
Neuroendocrine cancer 2B72.1 Investigative [5]
Octreotide Interacts with 1 DTT Molecule(s)
DTT Name DTT ID UniProt ID Mode of Action REF
Somatostatin receptor type 2 (SSTR2) TTZ6T9E SSR2_HUMAN Binder [15]
------------------------------------------------------------------------------------
Octreotide Interacts with 1 DTP Molecule(s)
DTP Name DTP ID UniProt ID Mode of Action REF
Multidrug resistance-associated protein 2 (ABCC2) DTFI42L MRP2_HUMAN Substrate [16]
------------------------------------------------------------------------------------
Octreotide Interacts with 13 DOT Molecule(s)
DOT Name DOT ID UniProt ID Mode of Action REF
Bile salt export pump (ABCB11) OTRU7THO ABCBB_HUMAN Decreases Activity [17]
Glycoprotein hormones alpha chain (CGA) OT00U3Y3 GLHA_HUMAN Decreases Secretion [18]
Thyrotropin subunit beta (TSHB) OTFDI39D TSHB_HUMAN Decreases Secretion [19]
Prolactin (PRL) OTWFQGX7 PRL_HUMAN Affects Expression [20]
Somatotropin (GH1) OT92RTRD SOMA_HUMAN Decreases Expression [21]
Insulin (INS) OTZ85PDU INS_HUMAN Decreases Expression [22]
Cellular tumor antigen p53 (TP53) OTIE1VH3 P53_HUMAN Decreases Expression [23]
Insulin-like growth factor I (IGF1) OTIIZR61 IGF1_HUMAN Decreases Expression [24]
Cholecystokinin (CCK) OT1GCG0L CCKN_HUMAN Decreases Secretion [25]
Tumor necrosis factor receptor superfamily member 6 (FAS) OTP9XG86 TNR6_HUMAN Increases Expression [26]
Caspase-3 (CASP3) OTIJRBE7 CASP3_HUMAN Increases Activity [27]
Tumor necrosis factor ligand superfamily member 6 (FASLG) OTZARCHH TNFL6_HUMAN Increases Expression [26]
Somatostatin (SST) OTY75GQH SMS_HUMAN Decreases Secretion [27]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 DOT(s)

References

1 ClinicalTrials.gov (NCT03061604) RCT to Determine the Efficacy of Combining Hemospray With Medical Treatment in Acute Variceal Bleeding
2 Ceftriaxone FDA Label
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5326).
4 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2055).
5 Octreotide FDA Label
6 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
7 Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64.
8 Intestinal transport of beta-lactam antibiotics: analysis of the affinity at the H+/peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial flux. Pharm Res. 1999 Jan;16(1):55-61.
9 Screening of antibiotics that interact with organic anion-transporting polypeptides 1B1 and 1B3 using fluorescent probes. Biol Pharm Bull. 2011;34(3):389-95.
10 Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother. 1996 Sep;38(3):409-24.
11 Determination of the antibiotic resistance rates of Serratia marcescens isolates obtained from various clinical specimens. Niger J Clin Pract. 2019 Jan;22(1):125-130.
12 Drug-resistant genes carried by Acinetobacter baumanii isolated from patients with lower respiratory tract infection. Chin Med J (Engl). 2010 Sep;123(18):2571-5.
13 Investigation of the effects of some drugs and phenolic compounds on human dihydrofolate reductase activity. J Biochem Mol Toxicol. 2015 Mar;29(3):135-9.
14 [Effects of octreotide on necrosis of hepatocellular carcinoma xenografts in nude mice]. Ai Zheng. 2009 Jul;28(7):673-8. doi: 10.5732/cjc.009.10055.
15 Versatile conjugation of octreotide to dendrimers by cycloaddition ("click") chemistry to yield high-affinity multivalent cyclic Peptide dendrimers. Bioconjug Chem. 2009 Jul;20(7):1323-31.
16 P-glycoprotein- and mrp2-mediated octreotide transport in renal proximal tubule. Br J Pharmacol. 2000 Jan;129(2):251-6.
17 A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicol Sci. 2013 Nov;136(1):216-41.
18 Treatment of thyroid-stimulating hormone-secreting adenomas with octreotide. Metabolism. 1992 Sep;41(9 Suppl 2):62-5. doi: 10.1016/0026-0495(92)90033-7.
19 Long-term efficacy and tolerability of octreotide treatment in acromegaly. Metabolism. 1992 Sep;41(9 Suppl 2):44-50. doi: 10.1016/0026-0495(92)90030-e.
20 Long-term treatment of acromegaly with a long-acting analogue of somatostatin, octreotide. Q J Med. 1990 Feb;74(274):189-201.
21 Effect of a somatostatin analogue, octreotide, on renal haemodynamics and albuminuria in acromegalic patients. Eur J Clin Invest. 1992 Jul;22(7):494-502. doi: 10.1111/j.1365-2362.1992.tb01496.x.
22 Effect of the somatostatin analogue, octreotide, on exercise-induced hypotension in human subjects with chronic sympathetic failure. Clin Sci (Lond). 1995 Oct;89(4):367-73. doi: 10.1042/cs0890367.
23 [Inhibitory effect of somatostatin analogue octreotide on the expression of p53 and Ras in human gastric cancer]. Nan Fang Yi Ke Da Xue Xue Bao. 2011 Jun;31(7):1245-8.
24 Pharmacokinetics, pharmacodynamics, and safety of microencapsulated octreotide acetate in healthy subjects. J Clin Pharmacol. 2000 May;40(5):475-81. doi: 10.1177/00912700022009242.
25 Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR. Aliment Pharmacol Ther. 2001 Feb;15(2):181-5. doi: 10.1046/j.1365-2036.2001.00924.x.
26 [Octreotide induces apoptosis of human hepatoma cells by the mechanism of facilitating the Fas/FasL gene expression therein]. Zhonghua Yi Xue Za Zhi. 2008 Mar 11;88(10):716-8.
27 Characterization of the functional and growth properties of long-term cell cultures established from a human somatostatinoma. Endocr Relat Cancer. 2006 Mar;13(1):79-93. doi: 10.1677/erc.1.00988.